EQT Life Sciences has exited its minority stake in Tubulis, a Germany-based clinical-stage biotech company developing next-generation antibody-drug conjugates.
Carmel Partners has closed its ninth multifamily real estate value creation fund on $1.35bn, below the $1.58bn it gathered for its predecessor vehicle in 2023.
KKR has raised about $23bn at the final close of its latest mammoth North America-focused private equity fund, the largest vehicle of its kind focused solely on that continent.
Hg has completed its take-private acquisition of enterprise finance management platform OneStream in an all-cash deal which values the business at about $6.4bn in equity.
Pan-European private equity investor Fremman Capital has reached an €808m final close for its sophomore fund, surpassing its €750m target in less than 18 months.